|
1
|
Halaby MJ and Yang DQ: p53 translational
control: A new facet of p53 regulation and its implication for
tumorigenesis and cancer therapeutics. Gene. 395:1–7. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji B, Harris BR, Liu Y, Deng Y, Gradilone
SA, Cleary MP, Liu J and Yang DQ: Targeting IRES-Mediated p53
Synthesis for Cancer Diagnosis and Therapeutics. Int J Mol Sci.
18:932017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Network TCGA; Cancer Genome Atlas Network,
: Comprehensive molecular portraits of human breast tumours.
Nature. 490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown CJ, Cheok CF, Verma CS and Lane DP:
Reactivation of p53: From peptides to small molecules. Trends
Pharmacol Sci. 32:53–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muller PA and Vousden KH: Mutant p53 in
cancer: New functions and therapeutic opportunities. Cancer Cell.
25:304–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryu HW, Shin DH, Lee DH, Choi J, Han G,
Lee KY and Kwon SH: HDAC6 deacetylates p53 at lysines 381/382 and
differentially coordinates p53-induced apoptosis. Cancer Lett.
391:162–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seidel C, Schnekenburger M, Dicato M and
Diederich M: Histone deacetylase 6 in health and disease.
Epigenomics. 7:103–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lorenzo Pisarello M, Masyuk TV, Gradilone
SA, Masyuk AI, Ding JF, Lee PY and LaRusso NF: Combination of a
Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist
Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model
of Polycystic Liver Disease. Am J Pathol. 188:981–994. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y and Yang DQ: The ATM inhibitor
KU-55933 suppresses cell proliferation and induces apoptosis by
blocking Akt in cancer cells with overactivated Akt. Mol Cancer
Ther. 9:113–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Halaby MJ, Hibma JC, He J and Yang DQ: ATM
protein kinase mediates full activation of Akt and regulates
glucose transporter 4 translocation by insulin in muscle cells.
Cell Signal. 20:1555–1563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Halaby MJ, Kastein BK and Yang DQ:
Chloroquine stimulates glucose uptake and glycogen synthase in
muscle cells through activation of Akt. Biochem Biophys Res Commun.
435:708–713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harris BRE, Zhang Y, Tao J, Shen R, Zhao
X, Cleary MP, Wang T and Yang DQ: ATM inhibitor KU-55933 induces
apoptosis and inhibits motility by blocking GLUT1-mediated glucose
uptake in aggressive cancer cells with sustained activation of Akt.
FASEB J. 35:e212642021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Golding SE, Rosenberg E, Valerie N,
Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M,
Rigoreau L, Menear KA, et al: Improved ATM kinase inhibitor
KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and
ERK prosurvival signaling, and inhibits migration and invasion. Mol
Cancer Ther. 8:2894–2902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jänicke RU, Sprengart ML, Wati MR and
Porter AG: Caspase-3 is required for DNA fragmentation and
morphological changes associated with apoptosis. J Biol Chem.
273:9357–9360. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang XH, Sladek TL, Liu X, Butler BR,
Froelich CJ and Thor AD: Reconstitution of caspase 3 sensitizes
MCF-7 breast cancer cells to doxorubicin- and etoposide-induced
apoptosis. Cancer Res. 61:348–354. 2001.PubMed/NCBI
|
|
16
|
Zhang B, Shetti D, Fan C and Wei K:
miR-29b-3p promotes progression of MDA-MB-231 triple-negative
breast cancer cells through downregulating TRAF3. Biol Res.
52:382019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iorns E, Drews-Elger K, Ward TM, Dean S,
Clarke J, Berry D, El Ashry D and Lippman M: A new mouse model for
the study of human breast cancer metastasis. PLoS One.
7:e479952012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Halaby MJ, Harris BR, Miskimins WK, Cleary
MP and Yang DQ: Deregulation of Internal Ribosome Entry
Site-Mediated p53 Translation in Cancer Cells with Defective p53
Response to DNA Damage. Mol Cell Biol. 35:4006–4017. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harris BRE, Wang D, Zhang Y, Ferrari M,
Okon A, Cleary MP, Wagner CR and Yang DQ: Induction of the p53
Tumor Suppressor in Cancer Cells through Inhibition of
Cap-Dependent Translation. Mol Cell Biol. 38:382018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
D'Assoro AB, Barrett SL, Folk C, Negron
VC, Boeneman K, Busby R, Whitehead C, Stivala F, Lingle WL and
Salisbury JL: Amplified centrosomes in breast cancer: A potential
indicator of tumor aggressiveness. Breast Cancer Res Treat.
75:25–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
D'Assoro AB, Busby R, Suino K, Delva E,
Almodovar-Mercado GJ, Johnson H, Folk C, Farrugia DJ, Vasile V,
Stivala F, et al: Genotoxic stress leads to centrosome
amplification in breast cancer cell lines that have an inactive
G1/S cell cycle checkpoint. Oncogene. 23:4068–4075. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Assoro AB, Busby R, Acu ID, Quatraro C,
Reinholz MM, Farrugia DJ, Schroeder MA, Allen C, Stivala F, Galanis
E, et al: Impaired p53 function leads to centrosome amplification,
acquired ERalpha phenotypic heterogeneity and distant metastases in
breast cancer MCF-7 ×enografts. Oncogene. 27:3901–3911. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen JQ and Russo J: Dysregulation of
glucose transport, glycolysis, TCA cycle and glutaminolysis by
oncogenes and tumor suppressors in cancer cells. Biochim Biophys
Acta. 1826:370–384. 2012.PubMed/NCBI
|
|
25
|
Barron CC, Bilan PJ, Tsakiridis T and
Tsiani E: Facilitative glucose transporters: Implications for
cancer detection, prognosis and treatment. Metabolism. 65:124–139.
2016. View Article : Google Scholar : PubMed/NCBI
|
